The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The other facility is in Neuville-sur-Saône, France. SINGAPORE — French ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products and could be used to respond to an emerging pandemic ...

Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching €880m ($916m) compared to a loss of €119m ($123.9m) in the same period ...